Annexin A5: Shifting from a diagnostic towards a therapeutic realm

Cellular and Molecular Life Sciences

Volumn 64, Issue 22, 2007, Pages 2859-2862

  Kenis, H ^a   Hofstra, L ^a   Reutelingsperger, C P M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Annexin A5; Apoptosis; Diagnosis; Phosphatidylserine; Therapy

Indexed keywords

DOXORUBICIN; LIPOCORTIN 5;

APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNITY; BINDING AFFINITY; CARDIOVASCULAR DISEASE; HEART INFARCTION; HEART TUMOR; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; NEOPLASM; PROTEIN BINDING; PROTEIN EXPRESSION; SHORT SURVEY;

ANIMALS; ANNEXIN A5; APOPTOSIS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; PHOSPHATIDYLSERINES;

EID: 38549136860     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7297-2     Document Type: Short Survey

References (42)

1. Reutelingsperger, C. P. (2001) Annexins: key regulators of haemostasis, thrombosis, and apoptosis. Thromb. Haemost. 86, 413-419.
2. Reutelingsperger, C. P., Hornstra, G. and Hemker, H. C. (1985) Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur. J. Biochem. 151, 625-629.
3. Romisch, J., Seiffge, D., Reiner, G., Paques, E. P. and Heimburger, N. (1991) In-vivo antithrombotic potency of placenta protein 4 (annexin V). Thromb. Res. 61, 93-104.
4. Reutelingsperger, C. P. and van Heerde, W. L. (1997) Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell. Mol. Life Sci. 53, 527-532.
5. Mosser, G., Ravanat, C., Freyssinet, J. M. and Brisson, A. (1991) Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J. Mol. Biol. 217, 241-245.
6. Andree, H. A., Stuart, M. C., Hermens, W. T., Reutelingsperger, C. P., Hemker, H. C., Frederik, P. M. and Willems, G. M. (1992) Clustering of lipid-bound annexin V may explain its anticoagulant effect. J. Biol. Chem. 267, 17907-17912.
7. Isas, J. M., Cartailler, J. P., Sokolov, Y., Patel, D. R., Langen, R., Luecke, H., Hall, J. E. and Haigler, H. T. (2000) Annexins Vand XII insert into bilayers at mildly acidic pH and form ion channels. Biochemistry 39, 3015-3022.
8. Kubista, H., Hawkins, T. E., Patel, D. R., Haigler, H. T. and Moss, S. E. (1999) Annexin 5 mediates a peroxide-induced Ca(2+) influx in B cells. Curr. Biol. 9, 1403-1406.
9. Speijer, H., Jans, S. W., Reutelingsperger, C. P., Hack, C. E., van derVusse, G. J. and Hermens, W. T. (1997) Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2. FEBS Lett. 402, 193-197.
10. Mira, J. P., Dubois, T., Oudinet, J. P., Lukowski, S., Russo-Marie, F. and Geny, B. (1997) Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition. J. Biol. Chem. 272, 10474-10482.
11. Krahling, S., Callahan, M. K., Williamson, P. and Schlegel, R. A. (1999) Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 6, 183-189.
12. Callahan, M. K., Williamson, P. and Schlegel, R. A. (2000) Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ. 7, 645-653.
13. Kenis, H., van Genderen, H., Deckers, N. M., Lux, P. A., Hofstra, L., Narula, J. and Reutelingsperger, C. P. (2006) Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp. Cell Res. 312, 719-726.
14. Munoz, L. E., Franz, S., Pausch, F., Furnrohr, B., Sheriff, A., Vogt, B., Kern, P. M., Baum, W., Stach, C., von Laer, D. et al. (2007) The influence on the immunomodulatory effects of dying and dead cells of Annexin V. J. Leukoc. Biol. 81, 6-14.
15. Gaipl, U. S., Munoz, L. E., Rodel, F., Pausch, F., Frey, B., Brachvogel, B., von der Mark, K. and Poschl, E. (2007) Modulation of the immune system by dying cells and the phosphatidylserine-ligand annexin A5. Autoimmunity 40, 254-259.
16. Brachvogel, B., Dikschas, J., Moch, H., Welzel, H., von der Mark, K., Hofmann, C. and Poschl, E. (2003) AnnexinA5is not essential for skeletal development. Mol. Cell. Biol. 23, 2907-2913.
17. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L. and Henson, P. M. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207-2216.
18. Koopman, G., Reutelingsperger, C. P., Kuijten, G. A., Keehnen, R. M., Pals, S. T. and van Oers, M. H. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-1420.
19. Vermes, I., Haanen, C., Steffens-Nakken, H. and Reutelingsperger, C. (1995)Anovel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184, 39-51.
20. Boersma, H. H., Kietselaer, B. L., Stolk, L. M., Bennaghmouch, A., Hofstra, L., Narula, J., Heidendal, G. A. and Reutelingsperger, C. P. (2005) Past, present, and future of annexin A5: from protein discovery to clinical applications. J. Nucl. Med. 46, 2035-2050.
21. Tait, J. F., Smith, C., Levashova, Z., Patel, B., Blankenberg, F. G. and Vanderheyden, J. L. (2006) Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods. J. Nucl. Med. 47, 1546-1553.
22. Prinzen, L., Miserus, R. J., Dirksen, A., Hackeng, T. M., Deckers, N., Bitsch, N. J., Megens, R. T., Douma, K., Heemskerk, J. W., Kooi, M. E. et al. (2007) Optical and magnetic resonance imaging of cell death and platelet activation using annexin a5-functionalized quantum dots. Nano Lett. 7, 93-100.
23. Huber, R., Berendes, R., Burger, A., Schneider, M., Karshikov, A., Luecke, H., Romisch, J. and Paques, E. (1992) Crystal and molecular structure of human annexin Vafter refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. J. Mol. Biol. 223, 683-704.
24. van den Eijnde, S. M., Boshart, L., Reutelingsperger, C. P. M., De Zeeuw, C. I. and Vermeij-Keers, C. (1997) Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Differ. 4, 311-316.
25. Dumont, E. A., Reutelingsperger, C. P., Smits, J. F., Daemen, M. J., Doevendans, P. A., Wellens, H. J. and Hofstra, L. (2001) Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat. Med. 7, 1352-1355.
26. Blankenberg, F. G., Katsikis, P. D., Tait, J. F., Davis, R. E., Naumovski, L., Ohtsuki, K., Kopiwoda, S., Abrams, M. J., Darkes, M., Robbins, R. C. et al. (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci .USA 95, 6349-6354.
27. Ntziachristos, V., Schellenberger, E. A., Ripoll, J., Yessayan, D., Graves, E., Bogdanov, A., Jr., Josephson, L. and Weissleder, R. (2004) Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc. Natl. Acad. Sci. USA 101, 12294 - 12299.
28. Hofstra, L., Liem, I. H., Dumont, E. A., Boersma, H. H., van Heerde, W. L., Doevendans, P. A., De Muinck, E., Wellens, H. J., Kemerink, G. J., Reutelingsperger, C. P. et al. (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356, 209-212.
29. Hofstra, L., Dumont, E. A., Thimister, P. W., Heidendal, G. A., DeBruine, A. P., Elenbaas, T. W., Boersma, H. H., van Heerde, W. L. and Reutelingsperger, C. P. (2001) In vivo detection of apoptosis in an intracardiac tumor. JAMA 285, 1841-1842.
30. Narula, J., Acio, E. R., Narula, N., Samuels, L. E., Fyfe, B., Wood, D., Fitzpatrick, J. M., Raghunath, P. N., Tomaszewski, J. E., Kelly, C. et al. (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat. Med. 7, 1347-1352.
31. Kietselaer, B. L., Reutelingsperger, C. P., Heidendal, G. A., Daemen, M. J., Mess, W. H., Hofstra, L. and Narula, J. (2004) Noninvasive detection of plaque instability with use of radio-labeled annexin A5 in patients with carotid-artery atherosclerosis. N. Engl. J. Med. 350, 1472-1473.
32. Belhocine, T. Z. and Blankenberg, F. G. (2005) 99mTc-Annexin A5 uptake and imaging to monitor chemosensitivity. Methods Mol. Med. 111, 363-380.
33. Rottey, S., Slegers, G., Van Belle, S., Goethals, I. and Van de Wiele, C. (2006) Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J. Nucl. Med. 47, 1813-1818.
34. Kartachova, M., van Zandwijk, N., Burgers, S., van Tinteren, H., Verheij, M. and Valdes Olmos, R. A. (2007) Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J. Clin. Oncol. 25, 2534-2539.
35. Tanaka, K., Einaga, K., Tsuchiyama, H., Tait, J. F. and Fujikawa, K. (1996) Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: an improved fibrinolytic agent targeted to phospholipid-containing thrombi. Biochemistry 35, 922-929.
36. Dillon, S. R., Constantinescu, A. and Schlissel, M. S. (2001) AnnexinVbinds to positively selected B cells. J. Immunol. 166, 58-71.
37. van den Eijnde, S. M., van den Hoff, M. J., Reutelingsperger, C. P., van Heerde, W. L., Henfling, M. E., Vermeij-Keers, C., Schutte, B., Borgers, M. and Ramaekers, F. C. (2001) Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci. 114, 3631-3642.
38. Adler, R. R., Ng, A. K. and Rote, N. S. (1995) Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol. Reprod. 53, 905-910.
39. Appelt, U., Sheriff, A., Gaipl, U. S., Kalden, J. R., Voll, R. E. and Herrmann, M. (2005) Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ. 12, 194-196.
40. Kenis, H., van Genderen, H., Bennaghmouch, A., Rinia, H. A., Frederik, P., Narula, J., Hofstra, L. and Reutelingsperger, C. P. (2004) Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 279, 52623-52629.
41. Mari, C., Karabiyikoglu, M., Goris, M. L., Tait, J. F., Yenari, M. A. and Blankenberg, F. G. (2004) Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radio-labeled annexin V. Eur. J. Nucl. Med. Mol. Imaging 31, 733-739.
42. Balasubramanian, K., Mirnikjoo, B. and Schroit, A. J. (2007) Regulated Externalization of Phosphatidylserine at the Cell Surface: IMPLICATIONS FOR APOPTOSIS. J. Biol. Chem. 282, 18357-18364.